Ranbaxy Laboratories

Headquarters in India

Ranbaxy Laboratories website: http://www.ranbaxy.com

 

🔎 Run a search for “Ranbaxy Laboratories”

Get RSS feed of these results

All stories

Article
24 September 2005

AIDS! What's your company doing? [India]

Author: Sangeeta Singh, rediff.com

...there is little corporate preparedness [in India] for it [HIV/AIDS] so, today, should you discover that a colleague has picked up the debilitating virus, chances are he or she will be fired under some pretext...On the positive side, there's...

Read more

Article
13 August 2005

Interview: Harvey E. Bale [Director General, International Federation of Pharmaceutical Manufacturers & Associations] - Patents, access to drugs is the issue

Author: M G Arun, Financial Express [India]

All countries have patent safeguards and have the right and ability to implement compulsory licensing in emergency circumstances...It is important for India and the rest of the world to have a good balance between implementation of innovation policies...

Read more

Article
9 August 2005

Treatment for all? Tough choices await as the world scales up its battle against Aids

Author: Andrew Jack, Financial Times

..."There is no real strategic approach, no real global leadership, and the policymakers are avoiding every thorny issue," says Ellen 't Hoen, head of Médecins sans Frontières' campaign for access to essential medicines...[M]edicines have become more...

Read more

Article
12 July 2005

[DOC] Response by Merck & Co., Inc., MSF pricing report

Author: Merck

Merck agrees on the importance of making our medicines available to those who need them. That is why we implemented a clear, straightforward HIV pricing policy more than four years ago. Under this policy, Merck makes no profit on the sale of our...

Read more

Article
27 April 2005

[PDF] Neglected diseases gets shot in arm

Author: Andrew Jack, Financial Times

While neglected diseases such as malaria and tuberculosis infect millions of people every year and kill hundreds of thousands, their concentration in low-income countries that have little ability to pay means the drugs industry has long turned its...

Read more

Article
21 March 2005

Global AIDS, cancer activists step up pressure against Indian patents bill

Author: AFP

Global health activists...stepped up pressure against a controversial Indian patents bill that would bar firms from producing cheap copies of brand name drugs, saying it threatened millions of people living with HIV-AIDS and cancer around the world. ...

Read more

Story
1 March 2005

GlaxoSmithKline, AstraZeneca, Merck, Pfizer & other firms join UK govt. in committing to increased access to essential medicines for poorest countries, including via differential pricing

See full story

Article
1 March 2005

[PDF] Increasing people’s access to essential medicines in developing countries: a framework for good practice in the pharmaceutical industry

Author: UK Department for International Development (DFID)

Responsibility for increasing access to essential medicines rests with the whole international community...In this context there is a particular role for pharmaceutical companies. As the producers of existing, and developers of new, medicines they can...

Read more

Article
1 January 2005

Companies linked to Burma

Author: Intl. Confederation of Free Trade Unions (ICFTU)

[Updated Jan 2005] The database has been compiled by the ICFTU, based on publicly available information. It is a database of companies which appear, from the information available, to have some form of relationship with Burma...This list is not...

Read more

Article
31 December 2004

[PDF] Business and Economic Development: Pharmaceutical Sector Report

Author: AccountAbility & Business for Social Responsibility

[refers to Merck, Novo Nordisk, Aspen Pharmacare, Grunenthal, Novartis, Citadel Aurobindo Biotech & Citadel Fine Pharmaceuticals (both part of Aurobindo Pharmaceuticals), Abbott Laboratories, Bristol Myers-Squibb, Pfizer, Schering-Plough, Eli...

Read more